Abstract:Abstract Abstract 1746 Dendritic cells (DC) initiate and direct immune responses. Plasmacytoid DC (pDC) produce type I interferon (IFN) in response to viral and/or bacterial challenge and have been implicated in the pathogenesis of a number of chronic inflammatory disesases. pDC also induce the generation of regulatory T cells (Treg) from naïve CD4+ T cells. Treg control the balance of T cell responses and maintain immune homeostasis so the primary contribution of pDC to Treg induction in disease states is an important question. Psoriasis is a common chronic inflammatory skin disease associated with over expression of type I IFN–inducible genes in patients and this response apparently overwhelms any pDC regulatory contribution. The numbers of peripheral blood Treg cells and pDC are decreased in psoriatic patients but why pDC fail to generate a significant counterbalancing Treg response in psoriasis is unknown. We compared purified blood pDC from normal donors with those from psoriasis donors, who were well and either untreated or only on topical therapy at the time of donation, for their ability to induce Treg. Freshly purified pDC from both normal and psoriasis donors lacked CD80 and CD83, but expressed similar amounts of HLA-DR and CD86. pDC from healthy psoriasis donors, when stimulated with TLR9 ligands, secreted high amounts of IL-6, expressed little surface inducible costimulator-ligand (ICOS-L, CD275) and exhibited low indoleamine 2, 3–dioxygenase (IDO) enzymatic activity compared to normal controls. To assess the capacity of pDC from psoriasis patients to induce the differentiation of naïve CD4+ T cells, we performed sequential co-culture experiments. In these, TLR-9 stimulated pDC from psoriasis patients failed to induce the differentiation of naïve CD4+ T cells into IL-10 secreting, functional regulatory T cells. In addition, the CD4+CD25+ T cells resulting from co-culture with psoriasis pDC were less effective in suppressing an allogeneic MLR. In contrast, the pDC from psoriasis patients, unlike those from normal donors, induced T cells capable of secreting IL-22. Further investigation as to why psoriatic pDC failed to induce Treg showed that the differentiated CD4+CD25+ (CD127-) T cells from these co-cultures expressed dramatically less Foxp3 following priming with psoriatic pDC. Exogenous kynurenine, to replace IDO restored the ability of psoriatic pDC to induce Treg. In conclusion, our data demonstrate that aberrant pDC produce dysfunctional Treg development in psoriasis and highlights the contributions of IL-6/IDO/CD275/IL-22 to the disease pathogenesis. This insight is now driving studies in other disease states, notably graft versus host disease, where our focus is on manipulating DC for therapeutic benefit. Disclosures: No relevant conflicts of interest to declare.

Splenic Stroma Drives Mature Dendritic Cells to Differentiate into Regulatory Dendritic Cells.

Splenic Stroma-Educated Regulatory Dendritic Cells Induce Apoptosis of Activated CD4 T Cells Via Fas Ligand-Enhanced IFN-γ and Nitric Oxide.

Endothelial Stroma Programs Hematopoietic Stem Cells to Differentiate into Regulatory Dendritic Cells Through Il-10

Regulatory dendritic cells program generation of interleukin-4–producing alternative memory CD4 T cells with suppressive activity

Transcription factor E2F1 suppresses dendritic cell maturation.

MCSF drives regulatory DC development in stromal co-cultures supporting hematopoiesis

JAK/STAT signaling pathway in the process of differentiation and maturation of Dendritic calls

Dendritic Cell SIRT1–HIF1α Axis Programs the Differentiation of CD4 + T Cells Through IL-12 and TGF-β1

Fas Signal Promotes the Immunosuppressive Function of Regulatory Dendritic Cells Via the ERK/β-catenin Pathway.

Early Apoptotic T Lymphocytes Induce DCs from Bone Marrow to Tolerogenic DCs

DEC-205 As a Marker of Dendritic Cells with Regulatory Effects on CD8 T Cell Responses.

Differential activation profiles of multiple transcription factors during dendritic cell maturation.

Transcriptional regulation of dendritic cell development and function

Mesenchymal Stem Cells Induce Mature Dendritic Cells into A Novel Jagged-2-Dependent Regulatory Dendritic Cell Population

The Development, Maturation, and Turnover Rate of Mouse Spleen Dendritic Cell Populations

Failure of Plasmacytoid Dendritic Cells to Drive Functional Regulatory T Cell Differentiation In Human Disease

Extracellular vesicles from mature dendritic cells (DC) differentiate monocytes into immature DC

Distinct functional capacities of mouse thymic and splenic dendritic cell populations

Reciprocal Control of T Helper Cell and Dendritic Cell Differentiation

Intrasplenic Steady-State Dendritic Cell Precursors That Are Distinct from Monocytes

Convergent Differentiation: Myeloid and Lymphoid Pathways to Murine Plasmacytoid Dendritic Cells